The gap between what gets approved and what actually resonates with HCPs

Pharma and Med Comms Agencies spend millions perfecting messages, positioning, claims, visuals, and sequencing – all with one goal in mind:Help Healthcare Professionals (“HCPs”) understand drugs better so they can use them confidently.

And yet, much of message development still relies on: 

• Retrospective research 
• Static reports 
• Averages that hide real-world variation 
• And a fair amount of educated guesswork 

The uncomfortable truth?

Most underperforming messages don’t fail because they’re wrong, they fail because they don’t resonate. Resonance is the missing link between creative brilliance and commercial impact. But resonance isn’t binary. It’s not “tested” or “approved.” 

It’s dynamic and it varies by: 

• Specialty 
• Experience level 
• Geography 
• Practice setting 
• Even workload and context 

What if you Pharma and Med Comm Agencies could see message resonance – and act on it?

Imagine being able to: 

• Quantify using Message Resonance Score™ on a 0.0 – 5.0 scale 
• See early warning signals before misalignment shows up in market data 
• Understand why a message is underperforming 
• Optimize wording and framing before launch, not after 
• Predict how a message will land with different physicians 

Let’s look at this through an example :

A message that lands at a Message Resonance Score™ score of 4.4/5 with oncologists might quietly struggle at 3.5/5 with nurses or community HCPs. By then, the opportunity cost is already baked in. This is not seen months later or buried in a PDF, but through the Message Resonance Score™. This is what message intelligence should look like. Better message resonance isn’t just a creative win – it’s an ROI multiplier.  

The Message Resonance Score™ links what HCPs say in real-life conversations to what they do. This enables teams to predict and prove impact and drive commercial outcomes through evidence-led decision-making. 

From “What performed?” to “What will resonate next?” 

The future in Pharma and healthcare advertising is not more data. It’s better interpretation and earlier action. Pharma and Med Comms Agencies that win will be the ones who can: 

• Move from retrospective reporting to predictive intelligence 
• Turn qualitative feedback into quantified signals 
• Align creative, strategy, and medical understanding around a single source of truth 

The Message Resonance Score™ becomes the common language between strategy, creative, medical, and commercial teams. The question isn’t whether resonance matters, it’s whether you can see it clearly enough to act on it.

Because every fractional improvement in understanding, every avoided misalignment, every optimized message, adds up to something bigger: 

• Stronger brands 
• Better HCPs decision-making 
• Better Patient outcomes 

And that’s a return no leader should ignore. 

Explore how Message Resonance Score™ and DrugVoice help Pharma and Med Comms Agencies quantify, predict, and improve HCP understanding before performance is locked in. Book in a call here.